The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walz, G.
Right arrow Articles by Strom, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walz, G.
Right arrow Articles by Strom, T. B.

The Journal of Immunology, Vol 144, Issue 11 4242-4248, Copyright © 1990 by American Association of Immunologists

ARTICLES

Transcriptional modulation of human IL-6 gene expression by verapamil

G Walz, B Zanker, C Barth, KJ Wieder, SC Clark and TB Strom
Charles A. Dana Research Institute, Boston, MA.

Calcium channel-blocking agents interfere with the initial increase of cytosolic calcium that follows mitogenic stimulation of T lymphocytes. In cultures of mitogen-stimulated PBMC, verapamil also blocked T cell accumulation of cytoplasmic IL-2-encoding mRNA. In sharp contrast, the addition of verapamil to PHA and PMA-stimulated PBMC augmented the mitogen-stimulated increases in nuclear transcription of IL-6-encoding mRNA, steady state levels of IL-6 encoding mRNA, and release of IL-6 bioactivity. These experiments indicated that an increased IL-6 transcriptional rate rather than stabilization of transcripts accounted for the increased cytoplasmic IL-6 mRNA levels and subsequent expression of IL-6 bioactivity. These effects were not produced by nicardipine, another potent calcium channel blocker, or EGTA. We suggest that a non-calcium-dependent, IL-6 regulatory factor, absent or inactive in verapamil-treated cultures, inhibits IL-6 gene activation in mitogen-stimulated PBMC. Failure to express this inhibitory factor would result in IL-6 gene superinduction at a transcriptional level.


This article has been cited by other articles:


Home page
 J. Virol.Home page
A. Owen, B. Chandler, P. G. Bray, S. A. Ward, C. A. Hart, D. J. Back, and S. H. Khoo
Functional Correlation of P-Glycoprotein Expression and Genotype with Expression of the Human Immunodeficiency Virus Type 1 Coreceptor CXCR4
J. Virol., November 1, 2004; 78(21): 12022 - 12029.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Suzuki, T. Nishimaki-Mogami, N. Tamehiro, K. Inoue, R. Arakawa, S. Abe-Dohmae, A. R. Tanaka, K. Ueda, and S. Yokoyama
Verapamil Increases the Apolipoprotein-Mediated Release of Cellular Cholesterol by Induction of ABCA1 Expression Via Liver X Receptor-Independent Mechanism
Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 519 - 525.
[Abstract] [Full Text]

Home page
 HypertensionHome page
Y. Funakoshi, T. Ichiki, K. Ito, and A. Takeshita
Induction of Interleukin-6 Expression by Angiotensin II in Rat Vascular Smooth Muscle Cells
Hypertension, July 1, 1999; 34(1): 118 - 125.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
O. Eickelberg, M. Roth, R. Mussmann, J. J. Rudiger, M. Tamm, A. P. Perruchoud, and L.-H. Block
Calcium Channel Blockers Activate the Interleukin-6 Gene Via the Transcription Factors NF-IL6 and NF-{kappa}B in Primary Human Vascular Smooth Muscle Cells
Circulation, May 4, 1999; 99(17): 2276 - 2282.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.